Domača stranB1MR34 • BVMF
add
Biomarin Pharmaceutical Inc Bdr
Prejšnji trg. dan.
160,17 R$
Dnevni razpon
160,17 R$ - 160,17 R$
Letni razpon
139,16 R$ - 208,72 R$
Tržna kapitalizacija
11,87 mrd. USD
Povprečni obseg
251,00
Razm. P/E
-
Dividendna donosnost
-
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 874,56 mio. | 17,03 % |
Stroški poslovanja | 209,05 mio. | −21,53 % |
Čisti dohodek | −46,57 mio. | −137,28 % |
Čista dobičkovnost prihodkov | −5,33 | −131,88 % |
Earnings per share | 0,46 | −50,00 % |
EBITDA | 217,83 mio. | 11,79 % |
Efektivna davčna stopnja | −71,52 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,56 mrd. | 37,17 % |
Skupna sredstva | 7,59 mrd. | 8,66 % |
Skupne obveznosti | 1,51 mrd. | 13,23 % |
Celoten lastniški kapital | 6,09 mrd. | — |
Shares outstanding | 192,30 mio. | — |
Razmerje P/B | 5,06 | — |
Donosnost sredstev | 6,49 % | — |
Donosnost kapitala | 7,40 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −46,57 mio. | −137,28 % |
Denar iz dejavnosti | 99,64 mio. | −46,32 % |
Denar iz naložb | −42,45 mio. | −155,56 % |
Denar iz financiranja | 3,16 mio. | 10,42 % |
Neto sprememba denarnih sredstev | 61,57 mio. | −76,97 % |
Prost denarni tok | 97,97 mio. | 16,80 % |
Vizitka
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Generalni direktor
Datum ustanovitve
mar. 1997
Sedež organizacije
Spletno mesto
Zaposleni
3.221
